Prodrug strategy for enhanced therapy of central nervous system disease
Crossref DOI link: https://doi.org/10.1039/D1CC02940A
Published Online: 2021
Update policy: https://doi.org/10.1039/rsc_crossmark_policy
Xia, Xue
Zhou, Yang
Gao, Huile https://orcid.org/0000-0002-5355-7238
Funding for this research was provided by:
Higher Education Discipline Innovation Project (B18035)
National Natural Science Foundation of China (81961138009)
Department of Science and Technology of Sichuan Province (2020YFS0570)
Accepted Manuscript valid from 2022-07-31
